QuintilesIMS to Announce Third-Quarter 2016 Results On November 2, 2016

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--()--Quintiles IMS Holdings, Inc. (“QuintilesIMS”) (NYSE:Q) will issue its third-quarter 2016 financial results before the market opens on Wednesday, November 2, 2016. The earnings release and accompanying financial information will be posted on the QuintilesIMS Investor Relations website at http://ir.quintilesims.com.

The QuintilesIMS management team will host a conference call and webcast to discuss the company’s results at 9:00 a.m. Eastern Time on November 2. Interested parties are invited to listen to the live event and view the presentation slides via webcast on the QuintilesIMS Investor Relations website at http://ir.quintilesims.com. The discussion also will be available by dialing +1-800-694-4033 in the U.S. and Canada, or +1-303-223-4393 for international callers.

A replay of the webcast will be available approximately two hours after the conclusion of the live event on November 2. To access the webcast recording, visit http://ir.quintilesims.com.

About QuintilesIMS

QuintilesIMS (NYSE:Q) is a leading integrated information and technology-enabled healthcare service provider worldwide, dedicated to helping its clients improve their clinical, scientific and commercial results. Formed through the merger of Quintiles and IMS Health, QuintilesIMS’s approximately 50,000 employees conduct operations in more than 100 countries. Companies seeking to improve real-world patient outcomes and enhanced clinical trial outsourcing through treatment innovations, care provision and access can leverage QuintilesIMS’s broad range of healthcare information, technology and service solutions to drive new insights and approaches. QuintilesIMS provides solutions that span clinical to commercial bringing clients a unique opportunity to realize the full potential of innovations and advance healthcare outcomes.

As a global leader in protecting individual patient privacy, QuintilesIMS uses healthcare data to deliver critical, real-world disease and treatment insights. Through a wide variety of privacy-enhancing technologies and safeguards, QuintilesIMS protects individual privacy while managing information to drive healthcare forward. These insights and execution capabilities help biotech, medical device, and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders in the development and approval of new therapies, identify unmet treatment needs and understand the safety, effectiveness and value of pharmaceutical products in improving overall health outcomes. To learn more, visit www.quintilesims.com/. QUINTILESIMSFIN

Click here to subscribe to Mobile Alerts for QuintilesIMS.

Contacts

Quintiles
Tom Kinsley, Investor Relations (thomas.kinsley@quintlesims.com)
+1.203.448.4691
or
Todd Kasper, Investor Relations (todd.kasper@quintilesims.com)
+1.919.998.2590
or
Phil Bridges, QuintilesIMS Media Relations (phil.bridges@quintilesims.com)
+1.919.998.1653 (office) +1.919.457.6347 (mobile)
or
Tor Constantino, QuintilesIMS Media Relations (tor.constantino@quintilesims.com)
+1.484.567.6732

Release Summary

QuintilesIMS to Announce Third-Quarter 2016 Results on November 2, 2016

Contacts

Quintiles
Tom Kinsley, Investor Relations (thomas.kinsley@quintlesims.com)
+1.203.448.4691
or
Todd Kasper, Investor Relations (todd.kasper@quintilesims.com)
+1.919.998.2590
or
Phil Bridges, QuintilesIMS Media Relations (phil.bridges@quintilesims.com)
+1.919.998.1653 (office) +1.919.457.6347 (mobile)
or
Tor Constantino, QuintilesIMS Media Relations (tor.constantino@quintilesims.com)
+1.484.567.6732